Skip to main content

Causal Impact and Statistics I

Image result for models in dresses
Image result for statistics

How can we use statistics to get at causal impact?

Of course, correlation does not imply causation. Remember my lesson from a Dilbert's comic last week. But still, there are inferences to be drawn somehow.

It may be a fact that MacDonald's just spent a lot of money on an ad campaign involving firecrackers and tapdancing penguins. It may be, also, that they sold a million hamburgers worldwide yesterday. It does not follow that they sold the million hamburgers because of that ad campaign. What MacDonald's clearly wants is some idea of how many hamburgers they would have sold if they had had some other ad campaign in place, possibly some less expensive campaign. Something involving their familiar clown and his sidekicks.

Here's a social sciency thing about "Bayesian structural time-series models" that aims at getting at the problem. It's actually based on the experiences of Google, paid clicks versus free clicks, etc. -- I just prefer the MacDonald's example, maybe because I'm hungry.

That phrase has the word "model" in it, so I'm putting a photo of a "model" above. Yuck yuck yuck.

It also has the word "Bayesian" in it, which I think I kinda understand.

One of the questions about social science cause-effect that has given me much pause in recent years is this: what, if anything, is the connection between a firm's labor policy and its indebtedness? There is an intuitive case to be made that indebted firms would be less desirable employers, other things being equal, than equity financed firms. After all, firms that have financed themselves through debt have to pay the interest as it comes due. Firms with a lot of equity on the balance sheet don't really have to pay dividends in a given quarter, they have discretion as to pay-out. So paying back debt investors is a higher priority than, say, keeping the workplace safe, or paying cost-of-living allowances in inflationary periods. But paying equity investors ... not necessarily. That's one way of looking at it. There are other ways.

But how do we determine this as a matter of empirical science? What statistics could persuade is that there is (or isn't) a connection between a firm's labor policy and its indebtedness? Can Bayesian structural time-series models help here?

More next week.


Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.

We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…